In humans, multiple genes have been implicated in muscular dystrophy; in addition, in most cases, any specific gene is implicated in multiple forms of the disease. This report describes muscular dystrophy, Duchenne type, which is one of several forms of the disease associated with the human gene dystrophin (DMD). Information about fly models for this and related diseases can be found in the report "muscular dystrophy, dystrophin-related' (FBhh0000191).
[updated Mar. 2016 by FlyBase; FBrf0222196]
[MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD](https://omim.org/entry/310200)
[DYSTROPHIN; DMD](https://omim.org/entry/300377)
Both the Duchenne and Becker forms of muscular dystrophy are associated with cardiomyopathy, which typically begins in adolescence. Signs and symptoms of dilated cardiomyopathy can include an irregular heartbeat (arrhythmia), shortness of breath, extreme tiredness (fatigue), and swelling of the legs and feet. These heart problems worsen rapidly and become life-threatening in many cases. [from Genetics Home Reference, Duchenne and Becker muscular dystrophy; 2016.03.11]
Muscular dystrophy, Duchenne type, is a severe form of the disease. It is initally characterized by a progressive proximal muscle wasting and weakness, with characteristic pseudohypertrophy of the calves. The bulbar muscles [of the mouth and throat] are spared, but the myocardium is affected. The onset of Duchenne muscular dystrophy usually occurs before age 3 years; typically the victim is chair-ridden by age 12 and dead by age 20. [from MIM:310200; 2016.03.11]
Duchenne muscular dystrophy (DMD) is caused by mutation in the gene encoding dystrophin (DMD); it shows an X-linked recessive pattern of inheritance. [from MIM:310200; 2016.03.11]
Severe elevation of creatine kinase levels in the blood, myopathic changes by electromyography, and myofiber degeneration with fibrosis and fatty infiltration on muscle biopsy are observed. [from MIM:310200; 2016.03.11]
Many to one: 3 human to 1 Drosophila; there are two lower-scoring orthologs in human, UTRN and DRP2.